| Primary |
| Hypotension |
38.9% |
| Orthostatic Hypotension |
16.7% |
| Wrist Fracture |
16.7% |
| Glioblastoma Multiforme |
11.1% |
| Postural Orthostatic Tachycardia Syndrome |
5.6% |
| Primary Adrenal Insufficiency |
5.6% |
| Syncope |
5.6% |
|
| Aortic Dissection |
13.3% |
| Product Substitution Issue |
13.3% |
| Suicidal Ideation |
13.3% |
| Unevaluable Event |
13.3% |
| Dizziness |
6.7% |
| Metabolic Alkalosis |
6.7% |
| Metastases To Lymph Nodes |
6.7% |
| Paranoia |
6.7% |
| Product Quality Issue |
6.7% |
| Rash |
6.7% |
| Weight Decreased |
6.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
38.4% |
| Glioblastoma Multiforme |
7.5% |
| Adrenal Insufficiency |
5.7% |
| Adrenogenital Syndrome |
5.7% |
| Pain |
5.7% |
| Multiple Myeloma |
5.0% |
| Addison's Disease |
3.8% |
| Metastatic Neoplasm |
3.1% |
| Orthostatic Hypotension |
3.1% |
| Prophylaxis |
3.1% |
| Chemotherapy |
2.5% |
| Septic Shock |
2.5% |
| Analgesic Therapy |
1.9% |
| Bronchitis Acute |
1.9% |
| Constipation |
1.9% |
| Hyponatraemia |
1.9% |
| Induction Of Anaesthesia |
1.9% |
| Routine Health Maintenance |
1.9% |
| Adrenocortical Carcinoma |
1.3% |
| Back Pain |
1.3% |
|
| Weight Decreased |
17.1% |
| Somnolence |
11.4% |
| Vomiting |
11.4% |
| Adrenocortical Insufficiency Acute |
5.7% |
| Drug Interaction |
5.7% |
| Infection |
5.7% |
| Tumour Haemorrhage |
5.7% |
| Abdominal Tenderness |
2.9% |
| Confusional State |
2.9% |
| Convulsion |
2.9% |
| Dehydration |
2.9% |
| Depression Suicidal |
2.9% |
| Dizziness |
2.9% |
| Drug Hypersensitivity |
2.9% |
| Electrolyte Imbalance |
2.9% |
| Gynaecomastia |
2.9% |
| Hypogonadism |
2.9% |
| Loss Of Consciousness |
2.9% |
| Nervous System Disorder |
2.9% |
| Presyncope |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.6% |
| Drug Use For Unknown Indication |
18.5% |
| Depression |
3.7% |
| Multiple Myeloma |
3.4% |
| Pain |
3.2% |
| Adrenal Insufficiency |
2.8% |
| Nuclear Magnetic Resonance Imaging |
2.5% |
| Hypertension |
2.3% |
| Constipation |
2.2% |
| Anxiety |
2.1% |
| Neoplasm Malignant |
2.0% |
| Osteoporosis |
2.0% |
| Atrial Fibrillation |
1.9% |
| Rheumatoid Arthritis |
1.9% |
| Adrenocortical Carcinoma |
1.6% |
| Parkinson's Disease |
1.6% |
| Adrenal Disorder |
1.5% |
| Type 1 Diabetes Mellitus |
1.5% |
| Hiv Infection |
1.4% |
| Hypotension |
1.4% |
|
| Weight Decreased |
12.0% |
| Vision Blurred |
10.3% |
| Vomiting |
8.6% |
| Pyrexia |
7.4% |
| Neutropenia |
6.9% |
| Death |
5.7% |
| Rhabdomyolysis |
4.6% |
| Diarrhoea |
4.0% |
| Fall |
4.0% |
| Hypotension |
4.0% |
| Syncope |
4.0% |
| Urinary Tract Infection |
4.0% |
| Fatigue |
3.4% |
| Serotonin Syndrome |
3.4% |
| White Blood Cell Count Increased |
3.4% |
| Drug Ineffective |
2.9% |
| International Normalised Ratio Increased |
2.9% |
| Loss Of Consciousness |
2.9% |
| Pneumonia |
2.9% |
| Pruritus |
2.9% |
|
| Interacting |
| Adrenogenital Syndrome |
44.4% |
| Adrenalectomy |
22.2% |
| Convulsion |
22.2% |
| Cardiac Failure |
11.1% |
|
|
